Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Fundação Oswaldo Cruz
2022
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=570575686008 https://www.redalyc.org/journal/5705/570575686008/ https://www.redalyc.org/journal/5705/570575686008/html/ https://www.redalyc.org/journal/5705/570575686008/570575686008.epub https://www.redalyc.org/journal/5705/570575686008/movil |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Technological order and technology transfer of the vaccine for COVID-19 in Brazil: a case study of the model used by AstraZeneca/Oxford and Fiocruz Silvania Iacovino Dantas Luciene Ferreira Gaspar Amaral Jorge Carlos Santos da Costa Multidisciplinaria (Ciencias Naturales y Exactas) ETEC COVID Demand 19 Vaccine Technological Order Introduction The COVID-19 pandemic, caused by SARS-CoV-2, showed a rapid increase in the number of cases and deaths in the five continents, with a major impact in the public health and the economy of the countries. The effects of COVID-19 have highlighted an increase in existing inequalities in society. A global mobilization for the development and rapid production of vaccines was needed to meet the emergency demand caused by COVID-19.Objective To discuss actions carried out by Fiocruz in the challenges imposed by the emergency to combat the disease, in addition to analyzing and discussing the partnership established between Bio-Manguinhos/Fiocruz and AstraZeneca, through Technological Order (ETEC), aiming at the verticalized Technology Transfer (TT) of the CHADOX1 NCOV-19 vaccine.Method A documentary analysis of a descriptive nature and qualitative approach was carried out, based on the search for scientific articles on the subject, and institutional documents, as well as a thorough procedural analysis of ETEC, formalized between Fiocruz and AstraZeneca.Results Although the National Policy for Technological Innovation in Health (PNITS) describes three viable legal instruments for formalizing partnerships, ETEC was the most adequate to meet the demands imposed by the health emergency of COVID-19, reinforcing the importance of using the State’s purchasing power as an instrument for strengthening the State Health Care System (SUS) within the scope of the Health Industrial Complex.Conclusions Even considering the health emergency caused by COVID-19, Bio-Manguinhos/Fiocruz managed to establish a partnership with AstraZeneca, aiming at the TT for the national verticalized production of the COVID-19 vaccine, for the attendance of SUS´s demand. The legal instrument chosen for the formalization of the partnership was ETEC, the first used in the public health area, which proved feasible to be reproduced in future partnerships aiming at the internalization of technologies of national interest. From the absorption of this technology, Bio-Manguinhos will be able to develop new vaccines of HM’s interest using the same technology. 2022 artículo científico 2317-269X https://www.redalyc.org/articulo.oa?id=570575686008 https://www.redalyc.org/journal/5705/570575686008/ https://www.redalyc.org/journal/5705/570575686008/html/ https://www.redalyc.org/journal/5705/570575686008/570575686008.epub https://www.redalyc.org/journal/5705/570575686008/movil 10.22239/2317-269X.02068 en http://www.redalyc.org/revista.oa?id=5705 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia application/pdf Fundação Oswaldo Cruz Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Brasil) Num.4 Vol.10